-
H. TAKAHASHI
Department of Clinical Cancer Chemotherapy, The Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University
-
H. ISHIGAKI
Department of Clinical Cancer Chemotherapy, The Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University
-
A. WAKUI
Department of Clinical Cancer Chemotherapy, The Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University
-
M. YOKOYAMA
Department of Clinical Cancer Chemotherapy, The Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University
-
Y. IRINODA
Department of Clinical Cancer Chemotherapy, The Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University
-
K. WATANABE
Department of Clinical Cancer Chemotherapy, The Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University
-
S. TADA
Department of Clinical Cancer Chemotherapy, The Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University
-
T. SAITO
Department of Clinical Cancer Chemotherapy, The Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University
